Management of Acute Agitation in Patients on Atypical Antipsychotics

Rationale for PRN Selection

• The American College of Emergency Physicians recommends haloperidol 5-10 mg IM as a PRN agent for acute undifferentiated agitation, with Level B evidence supporting its efficacy 1, 2, 3, 4
• Haloperidol provides a different mechanism of action from atypical antipsychotics like quetiapine, avoiding pharmacologic redundancy 1
• The use of haloperidol is supported by its proven safety profile, with well-characterized side effects that are manageable 1, 2

Dosing and Administration

• The American College of Emergency Physicians suggests starting with haloperidol 5 mg IM for initial management of acute agitation, with the option to repeat every 4-6 hours as needed 1, 3
• For more severe agitation, consider starting with haloperidol 10 mg IM 1

Important Considerations

• Monitor patients for extrapyramidal symptoms (EPS), which occur more frequently with haloperidol than atypicals, and have benztropine or diphenhydramine available for acute dystonic reactions 1, 2
• Consider prophylactic anticholinergics in young males at higher EPS risk 2
• Avoid haloperidol in patients with Parkinson's disease, Lewy body dementia, known prolonged QTc interval, anticholinergic toxicity, or sympathomimetic intoxication 1, 2, 4

Alternative Treatments

• For agitation not primarily psychotic in nature, consider lorazepam 2-4 mg IM, which is equally effective as haloperidol for undifferentiated agitation and avoids polypharmacy concerns with atypical antipsychotics 1, 2, 3, 4